However, when patients were then presented with a video detailing the dosing conditions required with oral semaglutide and those with once-weekly injectable dulaglutide, 52.5% indicated a preference for oral semaglutide [90]
The GLP-1 revolution, which started with relatively modest single-agonist drugs, has progressed to dual-agonists, then triple-agonists, and the pipeline continues to expand
Exceeding recommended doses (typically above 1,000 mg/day) increases the likelihood of digestive side effects such as bloating, cramping, and loose stools
This is because your doctor may stop treatment if weight loss is not achieved
Appetite may start creeping up toward the end of week two
For every 10 pounds you lose, somewhere between 2.5 and 4 pounds may be muscle tissue disappearing from your frame